LG Chem Q4 Operating Profit Falls 52.9 Pct To 290 Bln Won [Reuters]
Cue Biopharma, Inc. (CUE)
US:NASDAQ Investor Relations:
cuebiopharma.gcs-web.com/news-releases
Company Research
Source: Reuters
LG Chem Ltd (051910.KS) Key Developments | Reuters.com Jan 30 (Reuters) - LG Chem Ltd ::SAYS Q4 OPERATING PROFIT FALLS 52.9 PERCENT TO 290 BILLION WON ($259.79 million).SAYS IT PLANS 6.2 TRILLION WON ($5.55 billion) INVESTMENT IN 2019. Full Article Jan 30 (Reuters) - LG Chem Ltd says::TO PAY 2018 YEAR-END DIVIDEND OF 6,000 WON PER COMMON SHARE. Full Article Dec 19 (Reuters) - Kidman Resources Ltd ::ENTERED A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH LG CHEM IN RELATION TO SUPPLY OF LITHIUM HYDROXIDE.MOU CONTAINS COMMERCIAL TERMS IN RELATION TO SUPPLY OF 12KT OF LITHIUM HYDROXIDE PER ANNUM TO LG CHEM OVER A TERM OF 10 YEARS.OTHER COMMERCIAL TERMS OF MOU ARE CONFIDENTIAL..PARTIES HAVE AGREED TO WORK TOWARDS EXECUTION OF A BINDING STRATEGIC SUPPLY AGREEMENT BY 31 JULY 2019.MOU WITH LG CHEM REPRESENTS ABOUT 50 PERCENT OF KIDMAN'S SHARE OF LITHIUM HYDROXIDE PRODUCTION OF 22.6KT PER ANNUM. Full Article Dec 4 (Reuters) - GS Engineering & Construction Corp ::SAYS WINS ORDER WORTH
Show less
Read more
Impact Snapshot
Event Time:
CUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CUE alerts
High impacting Cue Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
CUE
News
- Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks [Yahoo! Finance]Yahoo! Finance
- Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswire
- Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]Yahoo! Finance
- Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.MarketBeat
CUE
Earnings
- 8/8/23 - Beat
CUE
Sec Filings
- 4/26/24 - Form DEF
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form ARS
- CUE's page on the SEC website